Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty.
- Creators
- Robert, Philippe
- Koening, Alexandra
- Amieva, Hélène
- Andrieu, Sandrine
- Bremond, Francois
- Bullock, Roger
- Ceccaldi, Mathieu
- Dubois, Bruno
- Gauthier, Serge
- Kenigsberg, Paul-Ariel
- Nave, S.
- Orgogozo, Jean-Marc
- Piano, Julie
- Benoit, Michel
- Touchon, Jacques
- Vellas, Bruno
- Yesavage, Jerome
- Manera, Valeria
- Others:
- Centre Mémoire de Ressources et de Recherche [Nice] (CMRR Nice) ; Université Nice Sophia Antipolis (1965 - 2019) (UNS) ; COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre Hospitalier Universitaire de Nice (CHU Nice)-Université Côte d'Azur (UCA)
- Department of Psychiatry and Neuropsychology ; University of Maastrich, Faculty of Psychology and Neuropsychology
- Epidémiologie et Biostatistique [Bordeaux] ; Université Bordeaux Segalen - Bordeaux 2-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP) ; Université Toulouse III - Paul Sabatier (UT3) ; Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Service Epidémiologie clinique et santé publique [CHU Toulouse] ; Pôle Santé publique et médecine publique [CHU Toulouse] ; Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
- Spatio-Temporal Activity Recognition Systems (STARS) ; Inria Sophia Antipolis - Méditerranée (CRISAM) ; Institut National de Recherche en Informatique et en Automatique (Inria)-Institut National de Recherche en Informatique et en Automatique (Inria)
- Kingshill Research Centre, Victoria Hospital ; Kingshill Research Centre, Victoria Hospital
- Centre Mémoire de Ressources et de Recherche ; CHU Marseille
- Institut de la Mémoire et de la Maladie d'Alzheimer [CHU Pitié-Salpétriêre] (IM2A) ; Université Pierre et Marie Curie - Paris 6 (UPMC)-CHU Pitié-Salpêtrière [AP-HP] ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
- Centre for Studies in Aging ; McGill University = Université McGill [Montréal, Canada]
- Fondation Médéric Alzheimer
- pRED ; Neurosciences Roche
- EA Cobteck ; Université Nice Sophia Antipolis (1965 - 2019) (UNS) ; COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)
- Palo Alto Veterans Affairs Health care System ; Stanford University
- Department of Psychiatry and Behavioral Sciences [Stanford] ; Stanford Medicine ; Stanford University-Stanford University
Description
Alzheimer's disease and other related disorders (ADRD) represent a major challenge for health care systems within the aging population. It is therefore important to develop better instruments to assess the disease severity and progression, as well as to improve its treatment, stimulation, and rehabilitation. This is the underlying idea for the development of Serious Games (SG). These are digital applications specially adapted for purposes other than entertaining; such as rehabilitation, training and education. Recently, there has been an increase of interest in the use of SG targeting patients with ADRD. However, this field is completely uncharted, and the clinical, ethical, economic and research impact of the employment of SG in these target populations has never been systematically addressed. The aim of this paper is to systematically analyze the Strengths, Weaknesses, Opportunities, and Threats (SWOT) of employing SG with patients with ADRD in order to provide practical recommendations for the development and use of SG in these populations. These analyses and recommendations were gathered, commented on and validated during a 2-round workshop in the context of the 2013 Clinical Trial of Alzheimer's Disease (CTAD) conference, and endorsed by stakeholders in the field. The results revealed that SG may offer very useful tools for professionals involved in the care of patients suffering from ADRD. However, more interdisciplinary work should be done in order to create SG specifically targeting these populations. Furthermore, in order to acquire more academic and professional credibility and acceptance, it will be necessary to invest more in research targeting efficacy and feasibility. Finally, the emerging ethical challenges should be considered a priority.
Abstract
International audience
Additional details
- URL
- https://hal.inria.fr/hal-01059594
- URN
- urn:oai:HAL:hal-01059594v1
- Origin repository
- UNICA